Literature DB >> 25189203

Kefir exhibits anti‑proliferative and pro‑apoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion.

Nathalie Khoury1, Stephany El-Hayek1, Omayr Tarras1, Marwan El-Sabban2, Mirvat El-Sibai1, Sandra Rizk1.   

Abstract

Kefir, a fermented milk product, exhibits anti‑tumoral activity in vivo; yet its mechanism of action remains elusive. Recent studies have focused on the mechanism of action of kefir on cancer cells in vitro. The current study aims at examining the effect of kefir on cell survival, proliferation, and motility of colorectal cancer (CRC) cells. Kefir's anti‑cancer potential was tested on CRC cell lines, Caco‑2 and HT‑29, through cytotoxicity, proliferation, and apoptotic assays. The expression of certain genes involved in proliferation and apoptosis was measured using reverse transcriptase‑polymerase chain reaction (RT‑PCR) and western blotting. To assess the effect of kefir on cancer metastasis, wound‑healing and time‑lapse movies, in addition to collagen‑based invasion assay, were used. The results show that cell‑free fractions of kefir exhibit an anti‑proliferative effect on Caco‑2 and HT‑29 cells. Analysis of DNA content by flow cytometry revealed the ability of kefir to induce cell cycle arrest at the G1 phase. Kefir was also found to induce apoptosis, as seen by cell death ELISA. Results from RT‑PCR showed that kefir decreases the expression of transforming growth factor α (TGF‑α); and transforming growth factor‑β1 (TGF‑β1) in HT‑29 cells. Western blotting results revealed an upregulation in Bax:Bcl‑2 ratio, confirming the pro‑apoptotic effect of kefir, and an increase in p53 independent‑p21 expression upon kefir treatment. MMP expression was not altered by kefir treatment. Furthermore, results from time‑lapse motility movies, wound‑healing, and invasion assays showed no effect on the motility of colorectal as well as breast (MCF‑7 and MB‑MDA‑231) cancer cells upon kefir treatment. Our data suggest that kefir is able to inhibit the proliferation and induce apoptosis in HT‑29 and Caco‑2 CRC cells, yet it does not exhibit a significant effect on the motility and invasion of these cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25189203     DOI: 10.3892/ijo.2014.2635

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  16 in total

Review 1.  Kefir: a powerful probiotics with anticancer properties.

Authors:  Mohammadreza Sharifi; Abbas Moridnia; Deniz Mortazavi; Mahsa Salehi; Marzieh Bagheri; Abdolkarim Sheikhi
Journal:  Med Oncol       Date:  2017-09-27       Impact factor: 3.064

2.  Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran.

Authors:  Susy Érika de Lima Barros; Henrique Barros de Lima; Leandra Karoline Alves Gonçalves; Lenir Cabral Correia; Maiara de Fátima de Brito Brito; Mariana Pegrucci Barcelos; Guilherme Martins Silva; Carlos Henrique Tomich de Paula da Silva; Rafael Garrett da Costa; Rodrigo Alves Soares Cruz; José Carlos Tavares Carvalho; Lorane Izabel da Silva Hage-Melim
Journal:  Toxicol Res (Camb)       Date:  2022-05-31       Impact factor: 2.680

3.  Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.

Authors:  Guang-Wei Yang; Jin-Song Jiang; Wei-Qin Lu
Journal:  Int J Mol Sci       Date:  2015-10-12       Impact factor: 5.923

Review 4.  Dairy products and colorectal cancer in middle eastern and north African countries: a systematic review.

Authors:  K El Kinany; M Deoula; Z Hatime; B Bennani; K El Rhazi
Journal:  BMC Cancer       Date:  2018-03-01       Impact factor: 4.430

5.  Inhibitory Effects of Probiotic Lactobacillus on the Growth of Human Colonic Carcinoma Cell Line HT-29.

Authors:  Zhung-Yuan Chen; You-Miin Hsieh; Chun-Chih Huang; Cheng-Chih Tsai
Journal:  Molecules       Date:  2017-01-10       Impact factor: 4.411

Review 6.  Kefir and Its Biological Activities.

Authors:  Nor Farahin Azizi; Muganti Rajah Kumar; Swee Keong Yeap; Janna Ong Abdullah; Melati Khalid; Abdul Rahman Omar; Mohd Azuraidi Osman; Sharifah Alawieyah Syed Mortadza; Noorjahan Banu Alitheen
Journal:  Foods       Date:  2021-05-27

7.  Metagenomic and phytochemical analyses of kefir water and its subchronic toxicity study in BALB/c mice.

Authors:  Muganti Rajah Kumar; Swee Keong Yeap; Nurul Elyani Mohamad; Janna Ong Abdullah; Mas Jaffri Masarudin; Melati Khalid; Adam Thean Chor Leow; Noorjahan Banu Alitheen
Journal:  BMC Complement Med Ther       Date:  2021-07-01

Review 8.  Milk kefir: composition, microbial cultures, biological activities, and related products.

Authors:  Maria R Prado; Lina Marcela Blandón; Luciana P S Vandenberghe; Cristine Rodrigues; Guillermo R Castro; Vanete Thomaz-Soccol; Carlos R Soccol
Journal:  Front Microbiol       Date:  2015-10-30       Impact factor: 5.640

Review 9.  The Role of Probiotics in Cancer Treatment: Emphasis on their In Vivo and In Vitro Anti-metastatic Effects.

Authors:  Elahe Motevaseli; Ali Dianatpour; Soudeh Ghafouri-Fard
Journal:  Int J Mol Cell Med       Date:  2017-05-31

10.  Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells.

Authors:  Marwa Al Hassan; Isabelle Fakhoury; Zeinab El Masri; Noura Ghazale; Rayane Dennaoui; Oula El Atat; Amjad Kanaan; Mirvat El-Sibai
Journal:  Anal Cell Pathol (Amst)       Date:  2018-06-26       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.